Derek R. Smith

Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: Increased interleukin‐4 production and associated eosinophilia

H. Weiner, D. Hafler, S. Khoury, 1997, Annals of neurology.

Seasonal variation of interferon‐γ production in progressive multiple sclerosis

H. Weiner, S. Khoury, M. Olek, 1998 .

Interferon-beta therapy for multiple sclerosis — Is the injection site the relevant action site?

Derek R. Smith, 2009, Journal of Neuroimmunology.

Cyclophosphamide Therapy for Multiple Sclerosis

Derek R. Smith, 2005 .

Preliminary analysis of a trial of pulse cyclophosphamide in IFN-β-resistant active MS

Derek R. Smith, 2004, Journal of the Neurological Sciences.

Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand.

H. Weiner, D. Hafler, S. Khoury, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.

H. Weiner, S. Khoury, D. Smith, 1998, The Journal of clinical investigation.

A randomized blinded trial of combination therapy with cyclophosphamide in patients with active multiple sclerosis on interferon beta

Xingchang Wei, H. Weiner, R. Bakshi, 2005, Multiple sclerosis.

Is Hepatitis B Vaccine Linked with Risk for MS

Derek R. Smith, 2004 .

Interferon-beta therapy for multiple sclerosis — Is the injection site the relevant action site?

Derek R. Smith, 2009, Journal of Neuroimmunology.